GLP-1 Weight Loss Drugs Lower U.S. Obesity in 2025: Health Revolution and What It Means
A groundbreaking shift is reshaping America’s approach to obesity. GLP-1 receptor agonists—medications originally designed for type 2 diabetes—are now transforming weight management across the United States in 2025, offering hope to millions struggling with obesity and its related health complications. The Rise of GLP-1 Medications in America GLP-1 (glucagon-like peptide-1) receptor agonists have emerged as … Read more